TechBio®
Over the past 15 years, Computer Science has seen tremendous progress in storage, networking, data analysis and computation power. The field of Life Science has also made tremendous strides in our understanding of biological processes and disease, leading to new therapies.
ARTIS invests at the convergence of these two industry trends. Investment focus areas include AI Drug Discovery, Synthetic Biology, Gene Editing, Digital Health, and more.
ARTIS Fellows will work closely with our investment team in due diligence, deal sourcing, and portfolio support.
Take part in shaping our Inaugural 6-month Fellows Program
Commit 10 hours per month remotely
Receive a competitive monthly stipend
Work directly with impactful healthcare startups
Learn about new cutting edge technologies on the TechBio frontier
Gain VC experience during a record setting market (2020: $51B invested in healthcare startups and $16B raised by healthcare VCs)
Applicants should be currently enrolled in a PhD or MD program (or Post-Doc / Residency). Expertise or interest in one of the following areas is preferred:
01
Cell & Gene Therapy
02
Immunology
03
AI / Machine Learning
04
Genetics
05
Neuroscience
06
Synthetic Biology
07
Metabolic Disorders
Applications for 2021 Now Open
Applications will close April 15, 2021.
Upon acceptance, AV Fellows will commence their six month commitment.
​
Please contact Megan Daugherty at md@av.co with any questions.
Artis Ventures is committed to increasing opportunities for underrepresented groups, promoting gender, racial, and ethnic diversity in the venture industry.